Navigation Links
Nutraceutical Reports Fiscal 2008 Q1 Results
Date:1/31/2008

PARK CITY, Utah, Jan. 31 /PRNewswire-FirstCall/ -- Nutraceutical International Corporation (Nasdaq: NUTR) today reported results for the fiscal 2008 first quarter ended December 31, 2007. Net sales for the fiscal 2008 first quarter were $41.1 million compared to $35.8 million for the same quarter of fiscal 2007. For the first quarter of fiscal 2008, net income was $3.2 million, or $0.28 diluted earnings per share, compared to net income of $3.4 million, or $0.30 diluted earnings per share, for the same quarter of fiscal 2007.

Bill Gay, chairman and chief executive officer, commented, "The growth in net sales of approximately 15% for the first quarter of fiscal 2008 compared to the same quarter of fiscal 2007 reflects the positive contributions of the six acquisitions completed during fiscal 2007. We remain focused on expanding our branded product sales through innovative marketing and sales programs that build long-term loyalty with our health and natural food store customers. Improved profitability and EBITDA from our acquisitions can normally be achieved within one to two years. Managing controllable expenses and gaining consolidation synergies from the fiscal 2007 acquired businesses will remain a dominant goal for the next few quarters. In spite of the current US economic slowdown, cost pressures and increasing competitive conditions, we remain confident in our business as we strive to serve our customers and take advantage of synergistic opportunities in the Healthy Foods Channel. We appreciate everyone that has helped us build a strong and successful business in the nutritional industry."

ABOUT NUTRACEUTICAL

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Our core business strategy is to acquire, integrate and operate, from beginning to end, the manufacturing, marketing and distribution of branded nutritional supplement businesses in the natural products industry. We believe that the consolidation and integration of these acquired businesses provides ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

We sell branded nutritional supplements and other natural products under the trademarks Solaray(R), VegLife(R), KAL(R), Nature's Life(R), Sunny Green(R), Action Labs(R), Natural Balance(R), NaturalMax(R), bioAllers(R), Herbs for Kids(TM), Natra-Bio(R), NaturalCare(R), Zand(R), Life-flo(R), Larenim(R), Living Flower Essences(R), Pioneer(R), Thompson(R), Natural Sport(R), Supplement Training Systems(R), Premier One(R), Montana Big Sky(TM), ActiPet(R), FunFresh Foods(TM), Dowd & Rogers(TM), CompliMed(R), AllVia(TM), Healthway(R), Body Gold(R), Sayge Biosciences(TM), Monarch Nutritional Laboratories(TM) and Great Basin Botanicals(TM). Under the name Woodland Publishing(TM), we publish, print and market a line of books and booklets to, among others, book distributors, national retail bookstores and health and

natural food stores. We also distribute branded products of certain third parties.

We own neighborhood natural food markets, which operate under the trade names The Real Food Company(TM), Thom's Natural Foods(TM) and Cornucopia Community Market(TM). We also own health food stores, which operate under the trade names Fresh Vitamins(TM), Granola's(TM) and Pilgrim's Natureway(TM).

We manufacture and/or distribute one of the broadest branded product lines in the industry with over 3,900 SKUs, including over 700 SKUs sold internationally. We believe that as a result of our emphasis on innovation, quality, loyalty, education and customer service, our brands are widely recognized in health and natural food stores and among their customers.

This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. We undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Press Release. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to, government regulations, product liability claims and litigation, insurance coverage issues, a decrease in or slowing of the growth rate of the vitamin, mineral and supplement market, the success of the healthy foods channel, consumer perception of safety and quality of our products and similar products, competition, intellectual property rights of other parties, the loss of key personnel, disruptions from acquisitions, issues with obtaining raw materials of adequate quality or quantity, problems with information management systems, manufacturing efficiencies and operations, litigation generally, the volatility of the stock market generally and of our stock specifically, a general lack of adequate industry analyst coverage, and other factors indicated from time to time in our SEC reports, copies of which are available upon request from our investor relations group or which may be obtained at the SEC's website (http://www.sec.gov).

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited; dollars in thousands)

December 31, September 30,

2007 2007

Assets

Current assets, net $49,904 $51,534

Property, plant and equipment, net 42,367 39,506

Goodwill 39,066 38,978

Other non-current assets, net 15,898 16,384

$147,235 $146,402

Liabilities and Stockholders' Equity

Current liabilities $17,725 $20,275

Long-term liabilities 21,227 20,208

Stockholders' equity 108,283 105,919

$147,235 $146,402

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited; dollars in thousands, except per share data)

Three months ended December 31,

2007 2006

Net sales $41,086 $35,848

Cost of sales 18,773 16,324

Gross profit 22,313 19,524

Operating expenses

Selling, general and administrative 16,628 13,922

Amortization of intangible assets 167 46

Income from operations 5,518 5,556

Interest and other (income)/expense, net 380 144

Income before provision for income taxes 5,138 5,412

Provision for income taxes 1,927 2,057

Net income $3,211 $3,355

Net income per common share

Basic $0.29 $0.30

Diluted 0.28 0.30

Weighted average common shares outstanding

Basic 11,123,792 11,015,967

Diluted 11,270,089 11,212,285

NUTRACEUTICAL INTERNATIONAL CORPORATION

EBITDA SCHEDULE

(unaudited; dollars in thousands)

Three months ended December 31,

2007 2006

Net income $3,211 $3,355

Provision for income taxes 1,927 2,057

Interest and other (income)/expense, net (1) 380 144

Depreciation and amortization 1,312 1,101

EBITDA $6,830 $6,657

(1) Includes amortization of deferred financing fees and losses associated

with fixed asset disposals.


'/>"/>
SOURCE Nutraceutical International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
2. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
3. Nutraceutical Reports 2007 Fiscal Year End Results
4. New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs
5. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
6. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
7. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
8. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
9. Encision Reports Third Fiscal Quarter Results
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Amylin Pharmaceuticals Reports 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , ... February 05, 2016 , ... US Sports ... Studio in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is ... just one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... The American ... technology, such water may be safer than regular municipal or well water. The recent ... radio host Sharon Kleyne, could go a long way toward increasing public acceptance of ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Give To ... users to search for and donate to Give To Cure’s campaign that is crowdfunding ... that lets users make and share payments through a smart device. In 2015 alone, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point ... Best in KLAS: Software & Services for HIT Implementation Support & Staffing report ... independently ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 ...
(Date:2/5/2016)... ... 05, 2016 , ... Dr. Justin Scott and Dr. Lydia Muccioli of ... Day to individuals in need. The event is scheduled to take place on February ... is to provide dental care to community members in need. Each patient will be ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016  Aralez Pharmaceuticals Inc. ("Aralez") today announced the ... Tribute Pharmaceuticals Canada Inc. ("Tribute") following approval of the ... The combined company will operate under Aralez Pharmaceuticals Inc. ... Canada , Ireland ... Under the terms of the Agreement and Plan of ...
(Date:2/5/2016)... New York , February 5, 2016 ... new Transparency Market Research report states that the global ... in 2014 and is predicted to reach US$185.9 bn ... CAGR of 6.50% from 2014 to 2020. The title ... (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic ...
(Date:2/5/2016)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... dental, animal health and medical practitioners, announced today that ... majority ownership interest in Dental Cremer S.A., a distributor ... . --> ... dental distribution business of Cremer S.A. With 2015 sales ...
Breaking Medicine Technology: